Human Data Can’t Wait for Clinical Trials.


Accelerating drug discovery with AIM Biotech’s humanized BioAvatar products & services.

From the most demanding basic research, to predictive screens for drug discovery, to the tailored selection of precision medicines, AIM Biotech enables and accelerates the development of cutting-edge therapeutics. This is made possible through AIM Biotech’s BioAvatar technology, which embodies our core expertise in the design and manufacture of sophisticated microfluidic systems and human tissue models. Our BioAvatars combine unmatched recapitulation of human biology with unparalleled ease-of-use, resulting in a powerful solution to move medicine forward.

BioAvatars enable:

Humanized pre-clinical insights

Humanized pre-clinical insights for increased predictability of clinical outcomes

drug discovery process

Acceleration of the drug discovery process through easy-to-implement humanized organ-on-a-chip models

Replacement of animal models

Replacement of animal models in pre-clinical trials

Explore AIM Biotech Solutions for Humanized Drug Discovery and Functional Precision Medicine

Introducing organiX: specifically made for Organoids and Biopsies

organiX is a revolution in Human Tissue and Biopsy Culture for Functional Precision Medicine and Drug Discovery

Designed to enable drug discovery and targeted therapies in large tissue samples like biopsies, organoids, tumoroids, spheroids and tissue aggregates, organiX allows for the detailed recreation of tissue and tumor microenvironments that is missing from current organoid research.

The ability to create actual physiological context for the study of these larger tissue samples is what sets organiX apart.

organiX Plate - Human Tissue | Translated.

organiX Plate

Amplify the power of organoid research and biopsy characterization with organiX


Culture – biopsies, organoids, tumor tumoroids, spheroids or any cell/tissue aggregate up to 2 mm in diameter


Contextualize – set assay conditions with perfusable vasculature, co-culture, signaling gradients and media flow for an in vivo-like tumor microenvironment (TME)


Extract – First, obtain real time high resolution imaging data and then easily extract tissue samples for downstream analysis

Level Up

Level Up! – Now revolutionize your fully contextualized organoid research utilizing conventional immunohistochemistry and next generation technologies like Digital Spatial Profiling

Your study. Our lab. Human data.

Contract research services for humanized, organ-on-a-chip studies

With AIM Biotech contract research services, increasing throughput while maintaining assay sophistication is our expertise. Our pharma-focused solutions combine speed and simplicity with the ability to model complex tissues that you expect from organ-on-a-chip assays.

Let AIM Biotech accelerate your drug discovery programs using our humanized BioAvatar Technology in our state-of-the-art research services lab. Our team can even work with you to design, develop, and execute custom assays to deliver human-focused, clinically-relevant results that move your drug discovery programs forward.

Custom assay development

Custom assay development

Custom assay development

Rapid humanized throughput

Functional immuno-oncology assays

Functional immuno-oncology assays

Answer primary research questions

Answer primary research questions

Data on routine screens

Data on routine screens

In-vitro organ models

In-vitro organ models

Your path to predictive data and insightful diagnostics.


Simple-to-use, fully scalable microfluidic systems in plate and chip formats to recapitulate human physiology.



Validated protocols in T-cell efficiency, immunotherapies, cell migration, vasculogenesis and more



Custom assay development and higher-throughput, high-content screening with assays of  your choice

Reportable’s software and service helps companies be heard and make sense of what’s being said.


Feasibility studies
Drug/target ID
Mechanism of action
Assay development

Drug Discovery

In vitro screening
Lead optimization
ADME toxicity studies
Safety pharmacology


Cohort selection
Personal/targeted Tx
Clinical avatar

AIM Biotech partners with Nikon to provide organ-on-a-chip imaging and analysis contract services for drug discovery

AIM Biotech partners with Nikon to provide organ-on-a-chip imaging and analysis contract services for drug discovery

Nikon Corporation announced on Wednesday that AIM Biotech is one of the select organ-on-a-chip (OOAC) providers to support Nikon’s expanding global contract research services for drug discovery. This partnership is a result of collaborative efforts between Nikon and AIM Biotech to demonstrate...